Chairman

Kingman P. Strohl, MD

Professor of Medicine, Case School of Medicine, Case Western Reserve University, Cleveland, Ohio

Disclosures

Disclosure: Kingman P. Strohl, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Galvani LLC; Inspire Medical Systems, Inc; Seven Dreamers Laboratories, Inc; Sommetrics, Inc
Received grants for clinical research from: National Institute of Health; Inspire Medical Systems, Inc; VA Research Service

Dr Strohl does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Strohl does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

Richard K. Bogan, MD

Chief Medical Officer, SleepMed Inc., Columbia, South Carolina

Disclosures

Disclosure: Richard K. Bogan, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Jazz Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: Jazz Pharmaceuticals, Inc.; Merck & Co., Inc.; Teva Pharmaceuticals USA; VANDA Pharmaceuticals; Xenoport
Received grants for clinical research from: Apnicure; Fisher and Paykel Appliances Ltd.; Jazz Pharmaceuticals, Inc.
Owns stock, stock options, or bonds from: SleepMed, Inc

Dr Bogan does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Bogan does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Patrick J. Strollo, MD

Professor of Medicine and Clinical Transitional Science, University of Pittsburgh, Pittsburgh, Pennsylvania

Disclosures

Disclosure: Patrick J. Strollo, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Belluscura Ltd.; Inspire Medical Systems, Inc; Itamar Medical Ltd; Jazz Pharmaceuticals, Inc.; Philips Respironics; ResMed
Received grants for clinical research from: Inspire Medical Systems, Inc; Jazz Pharmaceuticals, Inc.; Philips Respironics; ResMed

Dr Strollo does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Strollo does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

Karen Badal, MD, MPH

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Karen Badal, MD, MPH, has disclosed no relevant financial relationships.

CME Reviewer

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

CME

Improving Outcomes in OSA: Defining the Impact of Comorbidities on Care

Authors: Kingman P. Strohl, MD; Richard K. Bogan, MD; Patrick J. Strollo, MD
CME Released: 10/31/2017
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 11/28/2017, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for pulmonologists, neurologists, primary care physicians, psychiatrists and other healthcare providers who care for patients with OSA.

The goals of this activity are to provide participants with an increased awareness of comorbidities associated with obstructive sleep apnea and how to best apply the data to realistic patient case scenarios.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Identification of excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA)
- Strategies for the management of EDS
- Screening for cardiovascular disease in patients with OSA
- Recognition of comorbid narcolepsy in patients with OSA
Have greater competence related to
- Management of comorbidities associated with OSA

Chairman

Kingman P. Strohl, MD

Professor of Medicine, Case School of Medicine, Case Western Reserve University, Cleveland, Ohio

Disclosures

Disclosure: Kingman P. Strohl, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Galvani LLC; Inspire Medical Systems, Inc; Seven Dreamers Laboratories, Inc; Sommetrics, Inc
Received grants for clinical research from: National Institute of Health; Inspire Medical Systems, Inc; VA Research Service

Dr Strohl does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Strohl does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

Richard K. Bogan, MD

Chief Medical Officer, SleepMed Inc., Columbia, South Carolina

Disclosures

Disclosure: Richard K. Bogan, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Jazz Pharmaceuticals, Inc.
Served as a speaker or a member of a speakers bureau for: Jazz Pharmaceuticals, Inc.; Merck & Co., Inc.; Teva Pharmaceuticals USA; VANDA Pharmaceuticals; Xenoport
Received grants for clinical research from: Apnicure; Fisher and Paykel Appliances Ltd.; Jazz Pharmaceuticals, Inc.
Owns stock, stock options, or bonds from: SleepMed, Inc

Dr Bogan does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Bogan does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Patrick J. Strollo, MD

Professor of Medicine and Clinical Transitional Science, University of Pittsburgh, Pittsburgh, Pennsylvania

Disclosures

Disclosure: Patrick J. Strollo, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Belluscura Ltd.; Inspire Medical Systems, Inc; Itamar Medical Ltd; Jazz Pharmaceuticals, Inc.; Philips Respironics; ResMed
Received grants for clinical research from: Inspire Medical Systems, Inc; Jazz Pharmaceuticals, Inc.; Philips Respironics; ResMed

Dr Strollo does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Strollo does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

Karen Badal, MD, MPH

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Karen Badal, MD, MPH, has disclosed no relevant financial relationships.

CME Reviewer

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

processing....

This activity is in conjunction with a live symposium on October 31, 2017 in Toronto, Ontario, Canada

Having difficulty hearing the audio? Dial 855.364.7067 and enter the participant passcode 7849859 to listen via phone. For international callers or those who are unable to dial toll-free, please call 330.863.3280.

CME Information

Print
Like Tweet

Faculty and Disclosures

Chairman

Kingman P. Strohl, MD

Panelists

Richard K. Bogan, MD

Patrick J. Strollo, MD

Editor

Karen Badal, MD, MPH

CME Reviewer

Nafeez Zawahir, MD

CME

Improving Outcomes in OSA: Defining the Impact of Comorbidities on Care

Target Audience and Goal Statement

Chairman

Kingman P. Strohl, MD

Panelists

Richard K. Bogan, MD

Patrick J. Strollo, MD

Editor

Karen Badal, MD, MPH

CME Reviewer

Nafeez Zawahir, MD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Improving Outcomes in OSA: Defining the Impact of Comorbidities on Care